Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Addex Therapeutics

Request full access

Small-molecule drug development for neurological disorders

Geneva, SwitzerlandFounded 2002Biotech & Life Sciences

About Addex Therapeutics

Addex Therapeutics is a clinical-stage pharmaceutical company developing orally available small-molecule allosteric modulators for neurological disorders. Headquartered in Geneva, Switzerland, it was founded in 2002 by co-founders Vincent Mutel, Tim Dyer and Mark Epping-Jordan.

Its pipeline includes dipraglurant for post-stroke and traumatic brain injury recovery, alongside GABAB positive allosteric modulator programs for substance use disorder and chronic cough. Its proprietary clinical and preclinical drug candidates are developed both internally and through a partner.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2007

Addex Therapeutics in the Geneva ecosystem

Live from Dealroom

The Addex Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Michael J. Fox Foundation for Parkinson's Research
  • National Institutes of Health
  • Wellcome Trust
  • Innosuisse

Series A10 investors entered at this stage

  • Index Ventures
  • Sofinnova Partners
  • Medicxi
  • TVM Capital Life Science
  • Techno Venture Management
  • PolyTechnos Venture Partners
  • Vinci Capital
  • Renaissance
  • Initiative Capital
  • Bio*One Capital

Series B and later7 investors entered at this stage

  • SR One
  • Roche Venture Fund
  • Varuma
  • BVF Partners
  • NEA
  • Indivior
  • Armistice Capital
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Addex Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.